Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Presently, there are almost 100,000 people in Canada with COVID-19, the disease caused by the SARS CoV-2 virus, and almost 7000 have died. Although an effective vaccine is the ultimate goal, it is a long way off. To slow the spread and reduce the medical, social, and economic burdens, new treatments are needed. To find those, we need to know how the SARS CoV-2 virus works. In the proposed research, we will study two new proteins that SARS CoV-2 makes, which haven’t been seen in viruses before, to find out how they harm cells. We will also study a group of possible new drugs, the cannabinoids, to see if they can counteract the damage done by these viral proteins. This work will help scientists understand how the virus works in cells, to spur the development of new treatments. It may also uncover a new treatment for the virus, helping to save lives.
Robin Elaine Duncan
Maria Fernanda de Andrade Fernandes
Akseera Pharma Corp
Kinesiology
University of Waterloo
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.